B. Riley Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $849K | Sell |
3,429
-130
| -4% | -$28K | 0.05% | 341 |
|
|
2026
Q1 | $687K | Sell |
3,559
-9,197
| -72% | -$1.9M | 0.04% | 371 |
|
|
2025
Q4 | $2.63M | Buy |
12,756
+2,027
| +19% | +$405K | 0.12% | 169 |
|
|
2025
Q3 | $1.92M | Buy |
10,729
+1,203
| +13% | +$205K | 0.09% | 212 |
|
|
2025
Q2 | $1.54M | Buy |
+9,526
| New | +$1.52M | 0.07% | 255 |
|
|
2024
Q2 | – | Sell |
-20,584
| Closed | -$3.01M | – | 1461 |
|
|
2024
Q1 | $3.01M | Buy |
20,584
+12,634
| +159% | +$1.93M | 0.08% | 241 |
|
|
2023
Q4 | $1.26M | Sell |
7,950
-12,634
| -61% | -$1.81M | 0.03% | 463 |
|
|
2023
Q3 | $3.01M | Sell |
20,584
-4,725
| -19% | -$720K | 0.08% | 241 |
|
|
2023
Q2 | $3.88M | Sell |
25,309
-311
| -1% | -$48.5K | 0.09% | 231 |
|
|
2023
Q1 | $3.97M | Buy |
25,620
+3,928
| +18% | +$617K | 0.11% | 201 |
|
|
2022
Q4 | $3.34M | Buy |
21,692
+2,237
| +11% | +$330K | 0.09% | 226 |
|
|
2022
Q3 | $2.57M | Sell |
19,455
-400
| -2% | -$56.1K | 0.08% | 253 |
|
|
2022
Q2 | $2.69M | Buy |
19,855
+244
| +1% | +$33.6K | 0.11% | 187 |
|
|
2022
Q1 | $2.92M | Sell |
19,611
-1,443
| -7% | -$213K | 0.1% | 223 |
|
|
2021
Q4 | $3.41M | Sell |
21,054
-537
| -2% | -$86.8K | 0.1% | 221 |
|
|
2021
Q3 | $3.59M | Sell |
21,591
-81
| -0.4% | -$13.8K | 0.11% | 199 |
|
|
2021
Q2 | $3.74M | Buy |
21,672
+919
| +4% | +$152K | 0.12% | 192 |
|
|
2021
Q1 | $3.33M | Sell |
20,753
-7,712
| -27% | -$1.32M | 0.12% | 195 |
|
|
2020
Q4 | $4.78M | Buy |
28,465
+3,799
| +15% | +$616K | 0.26% | 89 |
|
|
2020
Q3 | $3.88M | Sell |
24,666
-3,427
| -12% | -$560K | 0.21% | 112 |
|
|
2020
Q2 | $4.71M | Buy |
28,093
+4,820
| +21% | +$756K | 0.31% | 82 |
|
|
2020
Q1 | $3.05M | Buy |
23,273
+8,304
| +55% | +$1.18M | 0.26% | 93 |
|
|
2019
Q4 | $2.23M | Buy |
14,969
+798
| +6% | +$110K | 0.19% | 119 |
|
|
2019
Q3 | $1.75M | Buy |
14,171
+1,392
| +11% | +$185K | 0.17% | 130 |
|
|
2019
Q2 | $1.8M | Buy |
12,779
+1,666
| +15% | +$230K | 0.2% | 105 |
|
|
2019
Q1 | $1.68M | Buy |
11,113
+253
| +2% | +$36.4K | 0.21% | 102 |
|
|
2018
Q4 | $1.35M | Buy |
10,860
+482
| +5% | +$65.9K | 0.19% | 119 |
|
|
2018
Q3 | $1.65M | Buy |
10,378
+198
| +2% | +$30K | 0.2% | 117 |
|
|
2018
Q2 | $1.43M | Buy |
10,180
+1,308
| +15% | +$180K | 0.19% | 130 |
|
|
2018
Q1 | $1.18M | Buy |
8,872
+5,300
| +148% | +$724K | 0.17% | 146 |
|
|
2017
Q4 | $445K | Buy |
+3,572
| New | +$441K | 0.06% | 346 |
|
|
2016
Q4 | – | Sell |
-14,792
| Closed | -$1.48M | – | 563 |
|
|
2016
Q3 | $1.48M | Sell |
14,792
-105
| -0.7% | -$10.3K | 0.29% | 82 |
|
|
2016
Q2 | $1.33M | Buy |
+14,897
| New | +$1.37M | 0.27% | 93 |
|
|
2015
Q4 | – | Sell |
-17,552
| Closed | -$1.78M | – | 582 |
|
|
2015
Q3 | $1.78M | Buy |
17,552
+830
| +5% | +$98.7K | 0.43% | 51 |
|
|
2015
Q2 | $2.07M | Buy |
+16,722
| New | +$2.02M | 0.52% | 40 |
|
|
2015
Q1 | – | Sell |
-19,733
| Closed | -$4.47K | – | 1037 |
|
|
2014
Q4 | $4.47K | Buy |
19,733
+4,574
| +30% | +$447K | 0.1% | 279 |
|
|
2014
Q3 | $1.39M | Buy |
15,159
+180
| +1% | +$15.6K | 0.36% | 60 |
|
|
2014
Q2 | $1.23K | Buy |
14,979
+200
| +1% | +$15.3K | ﹤0.01% | 2281 |
|
|
2014
Q1 | $1.13M | Sell |
14,779
-440
| -3% | -$34.3K | 0.34% | 61 |
|
|
2013
Q4 | $1.05M | Buy |
15,219
+2,026
| +15% | +$133K | 0.34% | 70 |
|
|
2013
Q3 | $855K | Sell |
13,193
-2,720
| -17% | -$172K | 0.29% | 76 |
|
|
2013
Q2 | $926K | Buy |
+15,913
| New | +$909K | 0.31% | 65 |
|
Other funds holding FBT
JWS
OPAM
QCIG
FFA
FEG
TCOO
SP
RA
IWM
B. Riley Wealth Advisors's FBT Position: Q2 2026 in Review
B. Riley Wealth Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.7% in Q2 2026, selling an estimated $28K and leaving 3,429 shares worth $849K. The position accounts for 0.05% of the portfolio, ranked #341.
B. Riley Wealth Advisors first reported a position in FBT in Q2 2013 and has held it in 42 quarters since. The position peaked at $4.78M in Q4 2020. 51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- B. Riley Wealth Advisors held 3,429 shares of First Trust NYSE Arca Biotechnology Index Fund worth $849K as of Q2 2026.
- B. Riley Wealth Advisors sold 130 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $28K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #341 holding.
- B. Riley Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 42 quarters since.
- B. Riley Wealth Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.78M in Q4 2020.
- 51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.